Answer
No pharmacokinetic drug–drug interaction studies have been conducted with cemiplimab.
Sources for this answer
- LIBTAYO 350 mg concentrate for solution for infusion.Regeneron UK Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 25Document updated
Sources checked